Clinical Trials Browser

Phase 4 × Ondansetron × Head & Neck × Clear all

NCT06697782 2025-01-22

Aprepitant and Ondansetron Monotherapy or Combination for Postoperative Nausea and Vomiting in Thyroid Cancer

Phase 4 Completed

Thyroid Neoplasms